MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Archives & Legacy
*Funding: Drug, Alcohol and Substance Abuse (Opioid Abuse)_Archives 2022-2023
2022: NIDA_Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)
The research projects supported by this FOA could include, but not limited to, the following:
Parents
2022: NIDA_Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)
Children
clinical trial designs can be developed in coordination with the FDA to support a DTx’s safety, effectiveness and other plans for gathering clinical evidence needed to support positive coverage decisions
Clinical trials
Cybersecurity Design Controls
Post marketing surveillance studies.
Research to address the considerations of cybersecurity and data rights as the preconditions for the mass adoption of DTx
Research to address the product designs that engage patients over long time periods, particularly, for older patients that may be less comfortable with smartphones or tablets
Research to assure that DTx fit into prescribing physicians' workflows
Research to integrate the role of the patient and/or the caregiver, e.g. as a user, as a tester, as a design partner